SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014914
Filing Date
2023-08-14
Accepted
2023-08-14 17:03:57
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmn-20230630x10q.htm   iXBRL 10-Q 1376237
2 EX-31.1 pmn-20230630xex31d1.htm EX-31.1 7907
3 EX-31.2 pmn-20230630xex31d2.htm EX-31.2 8582
4 EX-32.1 pmn-20230630xex32d1.htm EX-32.1 10734
  Complete submission text file 0001558370-23-014914.txt   5196229

Data Files

Seq Description Document Type Size
5 EX-101.SCH pmn-20230630.xsd EX-101.SCH 42151
6 EX-101.CAL pmn-20230630_cal.xml EX-101.CAL 32476
7 EX-101.DEF pmn-20230630_def.xml EX-101.DEF 101963
8 EX-101.LAB pmn-20230630_lab.xml EX-101.LAB 345529
9 EX-101.PRE pmn-20230630_pre.xml EX-101.PRE 248111
56 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20230630x10q_htm.xml XML 807001
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41429 | Film No.: 231171783
SIC: 2834 Pharmaceutical Preparations